Focusing on the evolution of disease spectrum, we apply patient demand-oriented precise R&D to meet every individual's diversified needs.
While inheriting the essence of TCM, we focus on innovation to cultivate superstars of Chinese medicine
Our research and development team blends TCM with state-of-the-art information technology to foster integrated innovation with TCM application. We perform cutting-edge research on TCM's mechanisms and pharmacodynamic properties. This consists of research approaches pertaining to TCM quality standards, microcirculation visualization techniques, gene network pharmacology, and application of medical big data. The network-based approach to drug-target interaction, clarification of drug-target interaction, dose efficiency, time course of therapeutic effects, and digitalization of the material basis have significantly improved the efficiency of drug R&D, allowing for precise, safe, and efficient drug innovation.
We exploit new path for globalization of TCM
We exploit new path for globalization of TCM
Tasly is the industry leader in advancing the modernization and globalization of TCM. We have completed the world's first international multi-center, randomized, double-blind, placebo-controlled Phase III clinical trial of T89 (Compound Danshen Dripping Pills) for product registration with the FDA. Additionally, we have partnered with Arbor, an American company, to conduct a series of clinical studies on T89 (Compound Danshen Dripping Pills), for product registration with the FDA. While demonstrating to the world that TCM is safe, effective, and quality-controllable, we have developed new ideas and models for globalizing TCM, and have achieved significant advances in this field.
We are the pioneer to lead TCM enterprises to go abroad
We are the pioneer to lead TCM enterprises to go abroad
Under the guidance of the State Administration of Traditional Chinese Medicine, and with support from major national new drug research and development projects, Tasly has partnered with 12 companies and 6 research institutes to build an international TCM research platform—the World Alliance of Traditional Chinese Medicine. We have helped 7 members apply for international patents for 8 products, accelerating the globalization of TCM. So far, we have launched more than 20 international R&D projects and established overseas branches in 16 countries or regions. Our marketing network covers more than 40 countries in the world, reaching nearly 1 million online customers.
